ArticleClinical kidney journal2025
Efficacy and safety of belimumab in refractory and newly diagnosed active lupus nephritis patients: a real-world observational study.
Ying Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it